Mylan Sues IRS For Nixing $42M In Patent Litigation Write-Offs
Mylan Inc. is fighting the IRS' decision to deny its bid to write off $42 million in legal fees incurred in 2014 defending patent infringement litigation over its generic drug activities, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article